Jennison Associates
FBIO icon

Jennison Associates’s Fortress Biotech FBIO Stock Holding History

Jennison Associates’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-109,660
Closed -$11.5M – 715
2013
Q3 		$11.5M Buy
109,660
+27,649
+34% +$3.39M 0.01% 472
2013
Q2 		$10.6M Buy
+82,011
New +$12.1M 0.01% 473

Other funds holding FBIO

EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
MOACM
Mutual of America Capital Management New York $10.3B AUM 43.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return

Jennison Associates's FBIO Position: Q4 2013 in Review

Jennison Associates sold out of Fortress Biotech (FBIO) in Q4 2013, closing a stake of 109,660 shares — an estimated $11.5M sold.

Jennison Associates first reported a position in FBIO in Q2 2013 and held it in 2 quarters. The position peaked at $11.5M in Q3 2013. 60 funds tracked by Wall St. Rank hold FBIO as of Q4 2013.

  • Jennison Associates reported no remaining Fortress Biotech position as of Q4 2013 after selling out during the quarter.
  • Jennison Associates sold 109,660 Fortress Biotech shares in Q4 2013, an estimated $11.5M.
  • Jennison Associates first reported a position in Fortress Biotech in Q2 2013 and held it in 2 quarters.
  • Jennison Associates's Fortress Biotech position peaked at $11.5M in Q3 2013.
  • 60 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2013.

Based on Jennison Associates's 13F filing for Q4 2013, filed 10 Feb 2014.